Pakistani Ankylosing Spondylitis Cohort with modifiable cardiovascular risk factors (PAS-CVD) study

Abrar Ahmed Wagan1, Paras Surahyo2

  • 1Abrar Ahmed Wagan, MBBS, FCPS, FACR Associate Professor of Rheumatology, Indus Medical College, Tando Mohammad Khan, Pakistan.

PubMed

Insights

Ankylosing Spondylitis (AS) patients show a high prevalence of modifiable cardiovascular risk factors like obesity and high triglycerides. Early management is crucial for preventing cardiovascular events in this population.

Area of Science:

  • Rheumatology and Cardiovascular Medicine

Background:

  • Ankylosing Spondylitis (AS) is a chronic inflammatory disease.
  • Cardiovascular disease (CVD) is a significant concern in AS patients.

Purpose of the Study:

  • To determine the frequency of modifiable cardiovascular risk factors in a Pakistani cohort with Ankylosing Spondylitis (AS).

Main Methods:

  • A cross-sectional study was conducted on 131 AS patients.
  • Data collected included demographics, blood pressure, body mass index, serum lipid profile, and fasting blood sugar.
  • The Framingham Risk Score (FRS) was calculated to categorize cardiovascular risk.

Main Results:

  • High prevalence of modifiable risk factors: obesity (75.6%), high triglycerides (62.6%), high FRS score (40.5%), high LDL (38.1%), low HDL (34.4%), hypertension (30.5%), diabetes mellitus (26.7%), high cholesterol (17.6%), and smoking (16%).
  • Increased disease duration in AS was associated with a higher risk of modifiable cardiovascular risk factors (p<0.05).

Conclusions:

  • Chronic AS is associated with a high prevalence of modifiable cardiovascular risk factors.
  • Early recognition and effective management of these risk factors are essential for preventing future cardiovascular events in AS patients.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
92
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
30
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
339
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
156
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.5K
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
13.4K